Leave Your Message
Explore our most trusted Zimeishu gynecological pad solutions — engineered with advanced silver-ion antimicrobial technology for effective, antibiotic-free feminine care.
The market for medicated and functional gynecological pads is expanding rapidly as women worldwide demand higher standards of intimate health, safety, and convenience.
The global feminine hygiene market is projected to surpass USD 42 billion by 2028. Within this sector, medicated gynecological pads represent one of the fastest-growing sub-segments, driven by rising health awareness and increasing prevalence of vaginal infections among adult women across Asia, Latin America, and Africa.
China has firmly established itself as a leading global supplier of gynecological and intimate care pads. With strict pharmaceutical-grade manufacturing standards, Chinese factories like Wanan Pharmaceutical deliver high-quality products at competitive costs, serving both domestic consumers and international B2B buyers through scalable OEM and ODM solutions.
Across Southeast Asia, the Middle East, and Sub-Saharan Africa, the awareness of gynecological health is rapidly improving. Gynecological pads are increasingly regarded not merely as hygiene products but as therapeutic devices — enabling over-the-counter infection management without the systemic side effects of antibiotics.
Silver ions (Ag⁺) have been recognized for millennia for their powerful antimicrobial properties. Zimeishu gynecological pads integrate pharmaceutical-grade silver-ion technology directly into the pad matrix, enabling rapid broad-spectrum sterilization of fungi, bacteria, and viruses — including the pathogens responsible for vaginal yeast infections (Candida albicans), bacterial vaginosis (Gardnerella vaginalis), and trichomoniasis. Unlike antibiotics, silver ions do not promote drug resistance, making Zimeishu pads a sustainable, long-term solution for recurrent gynecological conditions in adult women.
Designed with pharmaceutical precision, Zimeishu pads combine multiple advanced mechanisms to deliver comprehensive gynecological protection for adult women.
The silver-ion formula in Zimeishu gynecological pads achieves sterilization rates exceeding 99.9% against major pathogens within just minutes of application, providing near-immediate relief from itching, burning, and abnormal discharge associated with vaginal infections.
Healthy vaginal pH ranges from 3.8 to 4.5. Zimeishu's biochemically optimized pad formulation actively supports pH rebalancing, creating an inhospitable environment for pathogenic overgrowth while preserving beneficial Lactobacillus colonies critical for long-term vaginal health.
As antibiotic resistance becomes a global health crisis, Zimeishu offers an evidence-based, non-antibiotic approach to treating gynecological infections. Silver-ion therapy does not interfere with the body's microbiome or contribute to systemic drug resistance, making it safe for repeated use.
Manufactured under ISO 13485:2003 medical device standards, Zimeishu pads use hypoallergenic, dermatologically tested materials free from harmful chemicals, dyes, and synthetic fragrances — making them suitable for sensitive skin and long-term daily use in adult women.
Advanced multi-layer construction ensures rapid fluid absorption while maintaining exceptional air permeability. This combination prevents moisture buildup — a key factor in the proliferation of yeast and bacteria — while ensuring all-day comfort for active adult women.
Every Zimeishu gynecological pad is produced under ISO 9001:2000 quality management and ISO 13485:2003 medical device certifications, ensuring consistent pharmaceutical-grade quality, sterility, and safety across every batch shipped globally.
Understanding the diverse clinical and lifestyle contexts in which gynecological pads serve adult women helps highlight their indispensable role in modern women's health management.
Candida albicans overgrowth affects approximately 75% of women at some point in their lives. Zimeishu gynecological pads deliver localized silver-ion antifungal action directly to the affected area, reducing dependency on oral antifungal medications and enabling discreet, convenient daily treatment.
Bacterial vaginosis (BV) is the most common vaginal condition in women of reproductive age. Zimeishu antibacterial gynecological pads specifically formulated for BV help restore vaginal flora balance, neutralize pathogenic bacteria, and reduce recurrence rates in adult women managing chronic BV.
Beyond treating active infections, gynecological pads are increasingly adopted as part of proactive daily intimate hygiene routines. Women who are prone to recurrent infections, have hormonal imbalances, or are post-menopausal use functional gynecological pads to maintain baseline vaginal health continuously.
In clinical settings, medicated gynecological pads are prescribed as adjunct therapy following gynecological surgeries, cervical procedures, or childbirth. The antimicrobial and pH-balancing properties accelerate healing, reduce post-operative infection risks, and enhance patient comfort during recovery.
Women who travel frequently, work in physically demanding environments, or lack access to consistent hygiene facilities benefit significantly from portable, individually wrapped gynecological pads. The discrete format and long-lasting antimicrobial action provide reliable protection in diverse environmental conditions.
Declining estrogen during menopause and perimenopause alters vaginal pH and flora, significantly increasing susceptibility to infections and irritation. Gynecological pads with pH-buffering and antimicrobial properties provide targeted relief and protection, enhancing quality of life for mature adult women.
The industry is evolving rapidly. Here are the key trends shaping the next generation of gynecological pads for adult women worldwide.
Emerging R&D focuses on embedding micro-biosensors into gynecological pads that detect shifts in pH, glucose levels, or pathogen markers in vaginal secretions — enabling early infection detection and real-time health monitoring for adult women without the need for clinical testing.
Sustainability is reshaping feminine hygiene. Next-generation gynecological pads are being developed using plant-based, biodegradable materials that reduce environmental impact without compromising antimicrobial efficacy — addressing growing consumer demand for eco-conscious health products.
Advances in vaginal microbiome research are paving the way for personalized gynecological pad formulations. Future products may be tailored to individual microbiome profiles, delivering targeted probiotic or antimicrobial support based on a woman's unique biological needs and risk factors.
Regulatory frameworks in multiple countries are increasingly permitting pharmaceutical-grade medicated pads to be sold over-the-counter, reducing barriers to access. This trend is accelerating global market growth and enabling millions of women to self-manage gynecological conditions more effectively.
The sensitivity around gynecological health products has historically limited retail visibility. However, the explosion of e-commerce platforms has enabled brands like Zimeishu to reach adult women directly, with discreet packaging and subscription-based delivery models driving unprecedented consumer adoption.
Major international healthcare distributors and pharmacy chains are increasingly sourcing private-label gynecological pads from leading Chinese manufacturers. Wanan Pharmaceutical's capacity for OEM and ODM production positions it as a preferred B2B partner for global brands seeking factory-direct quality at scale.
Founded in 1995, Shaanxi Wanan Pharmaceutical Co., Ltd is a modern pharmaceutical enterprise incorporating scientific research, production, and sales. With fixed assets of approximately RMB 65 million Yuan (about USD 8 million) and annual sales exceeding RMB 50 million Yuan (about USD 6 million), Wanan Pharmaceutical currently employs over 300 professionals — 50% of whom are medical experts, including a scientific research group of 5 medical doctors and 11 masters, and an expert advisory group of more than 70 gynecological doctors.
Zimeishu silver-ion gynecological pad is Wanan's flagship product and demonstrates prominent clinical efficacy in preventing and treating gynecological inflammations. The product has achieved ISO 9001:2000 international quality certification and ISO 13485:2003 international medical equipment standards. Today, the Zimeishu sales network spans most major and medium-sized cities across China, having earned the trust of over 6 million women.
Discover the full range of Zimeishu gynecological pads — each engineered with silver-ion technology for targeted relief and prevention of vaginal infections in adult women.
In order to improve the life quality of women worldwide, the staff of Wanan — adhering to the philosophy of "Working with credibility and seeking for perfection" — and taking Zimeishu as the carrier of their deep passion, are committed to making meaningful contributions to the health and well-being of women everywhere. Whether you are a distributor, healthcare provider, or OEM partner, we welcome your inquiry.
Contact Wanan Pharmaceutical →